Skip to content

Iron supplement in Pregnant women

Comparative study Of different Iron Supplements and its Cost Effectiveness among Ante natal women with Iron Deficiency Anaemia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021380
Enrollment
84
Registered
2019-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

Intervention1: Ferrous ascorbate 200 mg: 200 mg orally twice daily for a period of 60 days Intervention2: Ferrous fumarate 200 mg: 200 mg twice orally dailyfor a period of 60 days Intervention3: Iron

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women between 18 to 40 years of age with more than 14 weeks of gestation and 2. Serum Haemoglobin levels between 9 - 11gm/dl for oral iron supplement and

Exclusion criteria

Exclusion criteria: 1.Pregnant women of less than 14 weeks of gestation. 2. Pregnant women with complications like bleeding piles, excessive emesis, active peptic ulcer, diabetes, hypertension, eclampsia, hypothyroidism and hyperthyroidism and multiple pregnancy. 3. Pregnant women not willing to sign written informed consent

Design outcomes

Primary

MeasureTime frame
To assess the Mean change in the haemoglobin levels from baseline upto 60th day of different iron supplementation in antenatal mothers with iron deficiency anaemia. To assess the cost effectiveness ratio of different iron preparations prescribed. Timepoint: Day 0 and Day 60

Secondary

MeasureTime frame
To compare the cost effectiveness of oral and parenteral iron supplements. To assess the tolerability of different iron supplements. Timepoint: Day 0 and day 60

Countries

India

Contacts

Public ContactSudakshina

Sri Venkateshwaraa Medical College hospital & research centre

saheerose@gmail.com9843591097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026